Results 61 to 70 of about 210,319 (126)
Prescribing pattern of anti-Parkinson drugs in Japan: a trend analysis from 2005 to 2010.
PLoS ONE, 2014 ObjectiveTherapeutic options for Parkinson's disease mainly consist of L-dopa and dopamine agonists. However, in Japan, the product labeling of the ergot dopamine agonists, cabergoline and pergolide, was revised in April 2007 due to the risk of ...
Sachiko Nakaoka +6 more
doaj +1 more source
Pramipexole use and the risk of pneumonia
BMC Neurology, 2012 Background Patients with Parkinson's disease have an elevated risk of pneumonia and randomized trials suggest that this risk may be increased with the dopamine agonist pramipexole.
Ernst Pierre +3 more
doaj +1 more source
New information of dopaminergic agents based on quantum chemistry calculations
Scientific Reports, 2020 Dopamine is an important neurotransmitter that plays a key role in a wide range of both locomotive and cognitive functions in humans. Disturbances on the dopaminergic system cause, among others, psychosis, Parkinson’s disease and Huntington’s disease ...
Guillermo Goode-Romero +6 more
doaj +1 more source
Journal of Pharmacological Sciences, 2010 Several reports have shown that some dopamine receptor ligands modulate the ischemia–reperfusion injury in animal models; however, its underling mechanisms are still unclear. In this study, we sought to establish an in vitro experimental model of hypoxia/
Saori Shimada +5 more
doaj +1 more source
Do neurologists in Germany adhere to the national Parkinson's disease guideline?
Neuropsychiatric Disease and Treatment, 2011 Sabrina Schröder1, Daniel Kuessner2, Guy Arnold3, York Zöllner4, Eddie Jones5, Marion Schaefer11Institute of Clinical Pharmacology, Charité University Medicine, CCM, Berlin, Germany; 2Basilea Pharmaceutica, Basel, Switzerland;
Sabrina Schröder +3 more
doaj
, 2005 Dopamine is a major neurotransmitter of the brain involved in the control of movement, emotion, and cognition; disturbance in dopamine function is associated with disorders like Parkinsons disease, schizophrenia and attention deficit hyperactivity ...
Dunnett, S. B.(Stephen B.)
core
BJPsych OpenAims: Dopamine agonists are prescribed to treat several major physical and mental illnesses. Rotigotine, ropinerole, pramipexole (full agonists) are routinely used to treat symptoms of restless leg syndrome, whilst aripiprazole (partial agonist) is used ...
John Barker, Rebecca Lees
doaj +1 more source
Dopamine D1 receptor agonists induce penile erections in rats
, 2003 The dopamine receptor agonist apomorphine has been recently introduced in the treatment of erectile dysfunction. While it is well established that dopamine D2-like receptors play a crucial role in this effect, conflicting result are reported in the ...
D'Aquila, Paolo Stefano +4 more
core
Dopamine agonists for treatment of restless legs syndrome
, 2006 The restless legs syndrome (RLS) is characterized by dysaesthesias of the legs associated with an urge to move which occurs at rest and during the night and can be ameliorated by activity. Treatment with levodopa leads to symptom relief, but augmentation
Happe, Svenja
core +2 more sources
Problematic gambling on dopamine agonists: not such a rarity
, 2006 Excessive gambling is recognized with dopamine agonist therapy, but the prevalence is unknown. We assessed the prevalence of excess gambling by specific prospective enquiry in Parkinson's disease patients attending six West Scotland movement disorder ...
Grosset, D.G. +6 more
core +1 more source